You just read:

DelMar to Present Poster of Clinical Research with VAL-083 in Patients with Chemo-Resistant Glioblastoma ("GBM") at ASCO Annual Meeting

News provided by

DelMar Pharmaceuticals, Inc.

Apr 27, 2017, 08:30 ET